Bipolar I Depression
6
0
0
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
16.7%
1 terminated out of 6 trials
83.3%
-3.2% vs benchmark
50%
3 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (6)
Lithium Effects on the Brain's Functional and Structural Connectome in the Treatment of Bipolar Disorder
A Study of Lurasidone Compared With Placebo for the Treatment of Bipolar I Depression
Lurasidone Pediatric Bipolar Study
Evaluating the Efficacy of Adjunctive Minocycline for the Treatment of Bipolar Depression
Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression